期刊文献+

非慢性阻塞性肺病单纯性右心衰竭的临床特征

下载PDF
导出
摘要 【目的】为临床上进一步认识非慢性阻塞性肺病单纯性右心衰竭(PRHF)提供经验及资料。【方法】回顾性总结28例(男12例,女16例,年龄46.1岁±18.6岁)由心脏或肺血管病变引起的 PRHF 病例的临床资料。【结果】引起 PRHF 最常见的心脏及肺血管病变是:原发性肺动脉高压、结缔组织病继发肺动脉高压、艾森曼格综合征。肺动脉栓塞是 PRHF 常见的合并症。PRHF 常见的临床表现是:气促、双下肢水肿、颈静脉怒张。大部分 PRHF 患者存在低氧血症、呼吸性碱中毒。其超声心动图的共同特点是:右心房和右心室增大,三尖瓣器质性或功能性关闭不全。药物治疗仍以利尿剂、扩张血管药和强心药居多。【结论】非慢性阻塞性肺病之 PRHF 有其自身特点,提示在治疗上应注意药物对血流动力学的不良影响。
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第B03期198-200,共3页 Journal of Sun Yat-Sen University:Medical Sciences
  • 相关文献

参考文献11

  • 1钱桂生,吴桂明.肺心病的诊断和治疗[M].北京:人民卫生出版社,1999.49-51.
  • 2Rafanan AL, Golish JA, Dinner DS, et al. Nocturnal hypoxemia is common in primary pulmonary hypertension[J]. Chest, 2001, 120(3):894-9.
  • 3Peacock AJ. Primary pulmonary hypertension[J]. Thorax, 1999, 54(12):1107-18.
  • 4Rich S, Kaufmarm E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension[J]. N Engl J Med, 1992, 327(2):76-81.
  • 5McLaughlin W, Genthner DE, Panella MM, et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension[J]. N Engl J Med, 1998, 338(5):273-7.
  • 6Barst R J, Rubin L1, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension[J|. N Engl J Med, 1996, 334(5):296-302.
  • 7Shapiro SM, Oudiz R J, Cao T, et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion [J]. J Am Coll Cardiol, 1997, 30(2):343-9.
  • 8McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy[J]. Circulation, 2002, 106(12): 1477-82.
  • 9Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival[J]. J Am Coll Cardiol, 2002, 40 (4):780-8.
  • 10Michelakis E, Tymchak W, Lien D, et al.Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide[J].Circulation, 2002, 105(20): 2398-403.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部